BridgeMD
New treatment option for Degeneration
Official title Vertebropexy - Randomized-controlled Trial
ClinicalTrials.gov ID: NCT06024785
What this study is testing
- What it's testing
- To assess the need for additional fusion surgery versus the risk of a revision surgery in patients with degenerative lumbar spinal disease and to assess efficacy and risk of the ligamentous fixation technique (vertebropexy)
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Single-level or two-level lumbar surgery needed
- Indication for decompression surgery in patients with spinal canal stenosis and additional stable degenerative listhesis (without facet joint...
- Indication for fusion surgery in patients with spinal canal stenosis and additional unstable degenerative listhesis (facet joint effusion ≥ 2mm), in...
- Understanding in German language
You likely can't join if
- Indication for decompression and/or fusion surgery in patients with solely disc herniation, fractures, lytic listhesis, tumor
- Patients undergoing revision surgery for infection
- Patients undergoing revision surgery on the same level if bony structures have been removed (e.g. prior laminectomy or midline decompression)
- Patients undergoing revision surgery in case of prior fusion surgery
- Inability to understand the study for linguistic or cognitive reasons
- Anticipated clinical follow-up of less than 6 weeks after inclusion
See the full eligibility criteria
- Age ≥ 18 years
- Single-level or two-level lumbar surgery needed
- Indication for decompression surgery in patients with spinal canal stenosis and additional stable degenerative listhesis (without facet joint effusion ≥ 2mm)
- Indication for fusion surgery in patients with spinal canal stenosis and additional unstable degenerative listhesis (facet joint effusion ≥ 2mm), in patients with foraminal stenosis and additional degenerative...
- Understanding in German language
- Indication for decompression and/or fusion surgery in patients with solely disc herniation, fractures, lytic listhesis, tumor
- Patients undergoing revision surgery for infection
- Patients undergoing revision surgery on the same level if bony structures have been removed (e.g. prior laminectomy or midline decompression)
- Patients undergoing revision surgery in case of prior fusion surgery
- Inability to understand the study for linguistic or cognitive reasons
- Anticipated clinical follow-up of less than 6 weeks after inclusion
- Participation in other clinical trials
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.